Searched for
CARFILZOMIB
Natco Pharma's marketing partner gets USFDA nod for anti-cancer drugNatco Pharma said based on the ANDA filing date, the company believes that it is eligible for 180 days of sole generic marketing exclusivit...- Top cancer drugs may come under price controlTaking cue from the WHO’s revised list of essential medicines, popular biosimilars for cancer cure may get incorporated in India’s revised ...
- Natco, Onyx settle cancer drug patent litigationThe Indian generic drug maker had partnered with Breckenridge Pharmaceutical for marketing its Carfilzomib injection in the US market.
- Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.
- Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...
Load More